Summary
As residential radon programmes of identification and remediation have proceeded, so questions have been raised about their costs and benefits. This study presents a generalizable model for estimating the cost-effectiveness of a radon mitigation programme using the methodological framework now considered appropriate in the economic evaluation of health interventions. Its use will help to inform future discussion of radon remediation and lung cancer prevention programmes. Data from Northamptonshire were analysed, resulting in a societal cost-effectiveness ratio of £13250 per life-year gained in 1997. The percentage of houses found to be over the action level, and the percentage of householders who decide to remediate are shown to be important parameters for the cost-effectiveness analysis. Questions are raised about the particular importance of perspective in this type of analysis and suggestions are made for future research directions.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bradley, EJ & Thomas, JM (1996). An Analysis of Responses to Radon Remediation Advice. Chilton, NRPB-M707, TSO: London
Bradley, EJ, Lomas, PR, Green, BMR & Smithard, J (1997). Radon in Dwellings in England 1997 Review. Chilton, NRPB-R293, TSO: London
Briggs, A, Sculpher, M & Buxton, M (1994). Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 3: 95–104.
Briggs, A & Gray, AM (1999). Handling uncertainty when performing evaluations of health care interventions. Health Technology Assessment, (in press)
Cancer Intelligence Unit (1992). Record queries. CIU: Oxford
Cancer Intelligence Unit (1998). Record queries. CIU: Oxford
Colgan, PA & Gutierrez, J (1996). Cost effectiveness of reducing radon exposure in Spanish dwellings. J Radiol Prot 16: 181–190.
Darby, S, Whitley, E, Silcocks, P, Thakrar, B, Green, M, Lomas, P, Miles, J, Reeves, G, Fearn, T & Doll, R (1998). Risk of lung cancer associated with residential radon exposure in south-west England: a case–control study. Br J Cancer 78: 394–408.
Department of Health and Social Security (1986). Breast Cancer Screening: Report of a Working Group (Sir Patrick Forrest, chairman) to the Ministers of England, Wales, Scotland and Northern Ireland. HMSO: London
Denman, AR & Phillips, PS (1998). A review of the cost effectiveness of radon mitigation in domestic properties in Northamptonshire. J Radiol Prot 18: 110–124.
Drummond, MF, Stoddart, GL & Torrance, GW (1997). Methods for the Evaluation of Health Care Programmes. OUP: Oxford
Godfrey, C, Hardman, G & Maynard, A (1989). Priorities for Health Promotion: An Economic Approach. Discussion Paper 59, Centre for Health Economics: York
Gold, MR, Siegel, JE, Russell, LB & Weinstein, MC (1996). Cost-Effectiveness in Health and Medicine. OUP: New York
HM Treasury (1997). Appraisal and Evaluation in Central Government. The Stationary Office: London
Hughes, JS & O’Riordan, M (1993). Radiation Exposure of the UK Population – 1993 Review, National Radiological Protection Board, Report R263. NPRB: Chilton
ICRP (1987). Lung Cancer Risk from Indoor Exposures to Radon Daughters, ICRP Publication 50, Ann, ICRP 17,
ICRP (1991). Recommendations of the International Commission on Radiological Protection, ICRP Publication 60, Ann: ICRP 20: 134
Johanesson, M, Jonsson, B, Kjekshus, J, Ollsson, AG, Pedersen, TR & Wedel, H (1997). Cost effectiveness of simvastatin treatment of lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med 336: 332–336.
Kendall, GM, Miles, JCH, Cliff, KD, Green, BMR, Muirhead, CR, Dixon, DW, Lomas, PR & Goodridge, SM (1994). Exposure to Radon in UK Dwellings. Chilton, NRPB-R272, TSO: London
Letourneau, EG, Krewski, D, Zielinski, JM & McGregor, RG (1992). Cost Effectiveness of radon mitigation in Canada. Radiat Prot Dosim 45: 593–598.
Marcinowski, F & Napolitano, S (1993). Reducing risks from radon. Air Waste 43: 955–962.
Mossman, KL & Sollitto, MA (1991). Regulatory control of indoor Rn. Health Phys 50: 169–176.
NRPB (1993). Estimates of late radiation risks to the UK population. Documents of the NRPB 4,
Phillips, PS & Denman, AR (1997). Radon: a human carcinogen. Sci Prog 80: 317–336.
Sanderson, H, Mountney, L & Harris, J (1992). Cancer of the lung. InHealth Care Needs Assessment, NHS Executive: London
Snihs, JO (1992). Swedish Radon Programme. Radiat Prot Dosim 42: 177–184.
United Nations Scientific Committee on the Effects of Atomic Radiation (1977). Sources and Effects of Ionizing Radiation. Report to the General Assembly, with Annexes, United Nations: New York
Wolstenholme JL Smith, SJ & Whynes, DK (1998). The costs of treating breast cancer in the United Kingdom: implications for screening. Intl J Technol Assess Health Care 14: 277–289.
Wolstenholme, JL & Whynes, DK (1999). The hospital costs of treating lung cancer in the United Kingdom. Br J Cancer, (in press)
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kennedy, C., Gray, A., Denman, A. et al. A cost-effectiveness analysis of a residential radon remediation programme in the United Kingdom. Br J Cancer 81, 1243–1247 (1999). https://doi.org/10.1038/sj.bjc.6690836
Received:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690836
